Congress returns from recess with five key U.S. health policy priorities including FY26 appropriations, OTC drug fee program reauthorization, drug pricing reform, Medicare/Medicaid extenders, and ACA tax credits.

Explore how frequent health insurance churn in the U.S. reduces insurers' incentives to invest in preventive care and chronic disease management, worsening health outcomes and increasing costs.

CMS to start AI-driven prior authorization pilot for traditional Medicare in Washington and five other states in 2026, targeting low-value procedures to reduce waste and improve compliance while maintaining clinician oversight.

CMS extends the AHEAD Model to 2035, introducing payment reforms and transparency to improve Medicare cost control, prevention, and population health outcomes.

Explore how Medicare Advantage's growth reshapes retiree coverage, employer health benefits, and taxpayer costs amid evolving Medicare policy and enrollment trends.

Rep. Mariannette Miller-Meeks outlines Medicaid reforms, rural healthcare funding, and economic growth initiatives for Southeast Iowa, emphasizing sustainability and community engagement requirements.

AdvaMed raises patient safety and legal concerns over CMS's proposed Medicare competitive bidding programme restart for durable medical equipment and devices.

Healthcare policy and insurance coverage issues, including Medicaid cuts and ACA subsidy expirations, are central to the 2026 U.S. midterm elections amid regulatory challenges at CDC and HHS.

Florida risks a major health insurance crisis as ACA premium tax credits expire in 2025, threatening coverage for millions and increasing premiums significantly, especially in Miami-Dade.

Explore how new respiratory health data influences insurance coverage, risk assessment, and regulatory compliance for U.S. insurers.